166 related articles for article (PubMed ID: 11133996)
21. Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
Zheng X; Johansson M; Karlsson A
J Biol Chem; 2000 Dec; 275(50):39125-9. PubMed ID: 10993893
[TBL] [Abstract][Full Text] [Related]
22. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines.
Sala-Newby GB; Freeman NV; Skladanowski AC; Newby AC
J Biol Chem; 2000 Apr; 275(16):11666-71. PubMed ID: 10766785
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Amsailale R; Van Den Neste E; Arts A; Starczewska E; Bontemps F; Smal C
Biochem Pharmacol; 2012 Jul; 84(1):43-51. PubMed ID: 22490700
[TBL] [Abstract][Full Text] [Related]
24. Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.
Galmarini CM; Warren G; Senanayake MT; Vinogradov SV
Int J Pharm; 2010 Aug; 395(1-2):281-9. PubMed ID: 20580798
[TBL] [Abstract][Full Text] [Related]
25. Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
Gallier F; Lallemand P; Meurillon M; Jordheim LP; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
PLoS Comput Biol; 2011 Dec; 7(12):e1002295. PubMed ID: 22174667
[TBL] [Abstract][Full Text] [Related]
26. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.
Mitra AK; Crews KR; Pounds S; Cao X; Feldberg T; Ghodke Y; Gandhi V; Plunkett W; Dolan ME; Hartford C; Raimondi S; Campana D; Downing J; Rubnitz JE; Ribeiro RC; Lamba JK
J Pharmacol Exp Ther; 2011 Oct; 339(1):9-23. PubMed ID: 21712425
[TBL] [Abstract][Full Text] [Related]
28. Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.
Ferrandina G; Mey V; Nannizzi S; Ricciardi S; Petrillo M; Ferlini C; Danesi R; Scambia G; Del Tacca M
Cancer Chemother Pharmacol; 2010 Mar; 65(4):679-86. PubMed ID: 19639316
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle dependent regulation of deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5'-nucleotidase I activity in MOLT-4 cells.
Fyrberg A; Mirzaee S; Lotfi K
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1201-4. PubMed ID: 17065091
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of recombinant bovine cytosolic 5'-nucleotidase IMP-GMP specific.
Allegrini S; Pesi R; Tozzi MG; Eriksson S
Adv Exp Med Biol; 1998; 431():231-5. PubMed ID: 9598065
[No Abstract] [Full Text] [Related]
31. Enforced expression of cytosolic 5'-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection.
Gray T; Morrey EL; Gangadharan B; Sumter TF; Spychala J; Archer DR; Spencer HT
Cancer Chemother Pharmacol; 2006 Jul; 58(1):117-28. PubMed ID: 16362297
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
[TBL] [Abstract][Full Text] [Related]
33. Purification and regulation of an AMP-specific cytosolic 5'-nucleotidase from dog heart.
Darvish A; Metting PJ
Am J Physiol; 1993 May; 264(5 Pt 2):H1528-34. PubMed ID: 8498566
[TBL] [Abstract][Full Text] [Related]
34. Cytosolic 5'-nucleotidase/nucleoside phosphotransferase: a nucleoside analog activating enzyme?
Turriani M; Pesi R; Nardone A; Turchi G; Sgarrella F; Ipata PL; Tozzi MG
J Biochem Toxicol; 1994 Feb; 9(1):51-7. PubMed ID: 8151632
[TBL] [Abstract][Full Text] [Related]
35. The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.
Cividini F; Pesi R; Chaloin L; Allegrini S; Camici M; Cros-Perrial E; Dumontet C; Jordheim LP; Tozzi MG
Biochem Pharmacol; 2015 Mar; 94(2):63-8. PubMed ID: 25656700
[TBL] [Abstract][Full Text] [Related]
36. Expression of cytosolic 5' nucleotidase does not correlate with expression of oxidative metabolism marker: myoglobine in human skeletal muscles.
Lechward K; Tkacz-Stachowska K
Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):280-4. PubMed ID: 19352542
[TBL] [Abstract][Full Text] [Related]
37. The enzymology of cytosolic pyrimidine 5'-nucleotidases: functional analysis and physiopathological implications.
Magni G; Amici A; Orsomando G
Curr Med Chem; 2013; 20(34):4304-16. PubMed ID: 23992312
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.
Walldén K; Stenmark P; Nyman T; Flodin S; Gräslund S; Loppnau P; Bianchi V; Nordlund P
J Biol Chem; 2007 Jun; 282(24):17828-36. PubMed ID: 17405878
[TBL] [Abstract][Full Text] [Related]
39. Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.
Yeo TK; Kintner J; Armand R; Perez R; Lewis LD
Hum Exp Toxicol; 2007 Dec; 26(12):911-21. PubMed ID: 18375634
[TBL] [Abstract][Full Text] [Related]
40. The functional logic of cytosolic 5'-nucleotidases.
Ipata PL; Balestri F
Curr Med Chem; 2013; 20(34):4205-16. PubMed ID: 23992316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
